Deutsche Bank Ag\ Impel Pharmaceuticals Inc Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$5.83 - $10.12 $17,000 - $29,509	-2,916 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.86 - $9.85 $2,039 - $3,427	-348 Reduced 10.66%	2,916 $19,000
Q4 2021 Feb 11, 2022	BUY	$8.33 - $12.14 $1,416 - $2,063	170 Added 5.49%	3,264 $28,000
Q3 2021 Nov 04, 2021	SELL	$8.38 - $26.13 $854 - $2,665	-102 Reduced 3.19%	3,094 $38,000
Q2 2021 Aug 11, 2021	BUY	$7.33 - $15.2 $23,426 - $48,579	3,196 New	3,196 $28,000

14.4K

Ticker IMPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,738,800
Market Cap $475K
Description
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.